Global Blood Therapeutics Announces Full Exercise Of Underwriter’s Option To Purchase Additional Shares

Global Blood Therapeutics, Inc. today announced that the underwriter of its previously announced underwritten public offering has exercised in full its option to purchase an additional 600,000 shares of GBT’s common stock.